Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020
- PMID: 32852265
- PMCID: PMC7588547
- DOI: 10.3201/eid2611.203504
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020
Abstract
In New Delhi, India, candidemia affected 15 critically ill coronavirus disease patients admitted to an intensive care unit during April-July 2020. Candida auris accounted for two thirds of cases; case-fatality rate was high (60%). Hospital-acquired C. auris infections in coronavirus disease patients may lead to adverse outcomes and additional strain on healthcare resources.
Keywords: 2019 novel coronavirus disease; COVID-19; Candida auris; India; SARS-CoV-2; antimicrobial resistance; co-infection; coronavirus disease; nosocomial infection; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
References
-
- He Y, Li W, Wang Z, Chen H, Tian L, Liu D. Nosocomial infection among patients with COVID-19: a retrospective data analysis of 918 cases from a single center in Wuhan, China. Infect Control Hosp Epidemiol. 2020;41:982–3.https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&li... 10.1017/ice.2020.126 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
